ArticleProceedings (Baylor University. Medical Center)2026

Comparing the risk of heart failure in patients with inflammatory bowel disease treated with infliximab versus adalimumab: a retrospective cohort study using a national database.

Hamza Almusabeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.